论文部分内容阅读
目的观察降纤酶联合葛根素葡萄糖注射液对急性脑梗死的治疗效果。方法将脑梗死患者随机分成降纤酶联合葛根素葡萄糖注射液治疗组与降纤酶对照组。对照组应用应用降纤酶第一天10U,第3,5天各5U;治疗组在此基础上应用葛根素葡萄糖注射液250ml静滴每日一次,连用14天。治疗前后对神经功能缺损进行评分。结果治疗组显效率74.3%,明显高于对照组67.9%,总有效率96.3%亦明显高于对照组85.7%(P<0.05)。结论降纤酶联合葛根素葡萄糖注射液治疗急性脑梗死能够明显改善临床症状,降低致残率。
Objective To observe the therapeutic effect of defibrase combined with puerarin glucose injection on acute cerebral infarction. Methods Patients with cerebral infarction were randomly divided into defibrase combined with puerarin glucose injection group and defibrase control group. In the control group, 10 U of defibrase was applied on day 1 and 5 U on day 3 and day 5. The treatment group was given 250 ml intravenous puerarin glucose injection once daily for 14 days. Neurological deficits were scored before and after treatment. Results The effective rate of the treatment group was 74.3%, significantly higher than that of the control group 67.9%, the total effective rate 96.3% was significantly higher than the control group 85.7% (P <0.05). Conclusion Defibrase combined with puerarin glucose injection for acute cerebral infarction can significantly improve the clinical symptoms and reduce the morbidity.